Building an Integrated Healthcare Platform Centered on Medical DX

「The Group aims to develop its healthcare platform business using medical DX, which will be fully rolled out from the fiscal year ending June 2027, as a new growth driver. It also aims to enhance corporate value over the medium to long term and achieve sustainable profit growth by actively expanding overseas, particularly in China and ASEAN, and pursuing M&A and business alliances.」

「Leveraging its strengths in medical expertise, R&D capabilities, know-how in obtaining evidence and its physician network, the Group plans to expand its business by building an integrated healthcare platform that combines online health consultations and medical consultations, second opinions, mail-in testing, PHR use and a mail-order business supporting self-medication. The platform will provide comprehensive support from prevention through treatment and the improvement of health literacy, while developing and providing services and products that contribute to maintaining and improving public health and using medical resources efficiently.」

「The Group is promoting medical DX and support for corporate health management. As challenges surrounding access to healthcare diversify, including population aging, shortages of healthcare professionals and growing health concerns among employees stationed overseas, the Group is building an integrated healthcare platform that combines online health consultation, online medical consultations, disease management, second-opinion services, mail-in testing and the use of PHR (Personal Health Record), together with a self-medication service integrating the sale of health supplements, OTC medicines, Kampo medicines and functional cosmetics. The platform is intended to provide access to healthcare and health support suited to each individual, anytime and anywhere.」